Alicia Ottati1, Michael Feuerstein. 1. Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Abstract
PURPOSE: The purpose of this research was to develop a brief, reliable self-report measure of work-related cognitive limitations in occupationally active breast cancer survivors. METHODS: A pooled dataset of working breast cancer survivors (n = 228) completed a self-report measure of work-related cognitive limitations, the Cognitive Symptom Checklist-Work-59 (CSC-W59). A cross-validation technique was employed such that the pooled participants were randomized into two separate groups in order to conduct exploratory factor analysis (EFA) of the CSC-W59 with one group (n = 114) and confirm the results with the second group (n = 114). RESULTS: EFA of the CSC-W59 identified 21 items with a consistent factor loading of .4 or higher on three separate subscales (Working Memory, Executive Function, and Task Completion). These findings resulted in a 21-item, self-report measure referred to as the Cognitive Symptom Checklist-Work-21 (CSC-W21). The CSC-W21 demonstrated internal reliability (α = .88). Construct validity of the CSC-W21 is supported by significant positive correlations with cancer stage, job stress, and affective state. CONCLUSIONS: Brief, valid, internally reliable self-report measures such as the CSC-W21 may be used to quickly assess work-related cognitive problems for breast cancer survivors at work. IMPLICATIONS FOR CANCER SURVIVORS: A brief measure is available to help identify tasks that present problems for breast cancer survivors who are at work. This measure can be used to facilitate research to improve the understanding and mitigation of cognitive challenges in breast cancer survivors in the work setting.
RCT Entities:
PURPOSE: The purpose of this research was to develop a brief, reliable self-report measure of work-related cognitive limitations in occupationally active breast cancer survivors. METHODS: A pooled dataset of working breast cancer survivors (n = 228) completed a self-report measure of work-related cognitive limitations, the Cognitive Symptom Checklist-Work-59 (CSC-W59). A cross-validation technique was employed such that the pooled participants were randomized into two separate groups in order to conduct exploratory factor analysis (EFA) of the CSC-W59 with one group (n = 114) and confirm the results with the second group (n = 114). RESULTS: EFA of the CSC-W59 identified 21 items with a consistent factor loading of .4 or higher on three separate subscales (Working Memory, Executive Function, and Task Completion). These findings resulted in a 21-item, self-report measure referred to as the Cognitive Symptom Checklist-Work-21 (CSC-W21). The CSC-W21 demonstrated internal reliability (α = .88). Construct validity of the CSC-W21 is supported by significant positive correlations with cancer stage, job stress, and affective state. CONCLUSIONS: Brief, valid, internally reliable self-report measures such as the CSC-W21 may be used to quickly assess work-related cognitive problems for breast cancer survivors at work. IMPLICATIONS FOR CANCER SURVIVORS: A brief measure is available to help identify tasks that present problems for breast cancer survivors who are at work. This measure can be used to facilitate research to improve the understanding and mitigation of cognitive challenges in breast cancer survivors in the work setting.
Authors: Anthony E Dragun; Bin Huang; Saurabh Gupta; John B Crew; Thomas C Tucker Journal: Int J Radiat Oncol Biol Phys Date: 2012-08-01 Impact factor: 7.038
Authors: Michael Feuerstein; Briana L Todd; Michal C Moskowitz; Gina L Bruns; Mallori R Stoler; Thomas Nassif; Xinhua Yu Journal: J Cancer Surviv Date: 2010-10-14 Impact factor: 4.442
Authors: Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root Journal: Brain Stimul Date: 2020-04-27 Impact factor: 8.955
Authors: Andy S K Cheng; Yingchun Zeng; Xiangyu Liu; Shaxin Liu; Stella W C Cheng; Cindy T T Kwok; Raymond C K Chung; Jianfei Xie; Michael Feuerstein Journal: J Cancer Surviv Date: 2018-09-18 Impact factor: 4.442
Authors: Jeanne S Mandelblatt; Robert A Stern; Gheorghe Luta; Meghan McGuckin; Jonathan D Clapp; Arti Hurria; Paul B Jacobsen; Leigh Anne Faul; Claudine Isaacs; Neelima Denduluri; Brandon Gavett; Tiffany A Traina; Patricia Johnson; Rebecca A Silliman; R Scott Turner; Darlene Howard; John W Van Meter; Andrew Saykin; Tim Ahles Journal: J Clin Oncol Date: 2014-05-19 Impact factor: 44.544
Authors: AnneClaire G N M Zaman; Kristien M A J Tytgat; Jean H G Klinkenbijl; Monique H W Frings-Dresen; Angela G E M de Boer Journal: BMC Cancer Date: 2016-05-10 Impact factor: 4.430
Authors: H F Dorland; F I Abma; C A M Roelen; A Smink; M Feuerstein; B C Amick; A V Ranchor; U Bültmann Journal: J Cancer Surviv Date: 2015-11-30 Impact factor: 4.442